出版：MarketsandMarkets（マーケッツアンドマーケッツ） 出版年月：2023年 1月
圧迫療法市場 : 技術、製品 (包帯、ラップ、ストッキング、テープ、装具、ポンプ)、用途 (静脈瘤、DVT、リンパ浮腫潰瘍)、流通チャネル (病院、診療所、薬局、電子商取引) – 2027年までの世界予測
Compression Therapy Market by Technique, Product (Bandages, Wraps, Stockings, Tapes, Ortho Braces, Pump), Application (Varicose Vein, DVT, Lymphedema Ulcer), Distribution Channel(Hospitals, Clinics, Pharmacies, E-Commerce) – Global Forecast to 2027
| ページ数 | 226 |
| 図表数 | 169 |
| 種別 | 英文調査報告書 |
| 価格 |
The compression therapy market size is expected to grow from an estimated USD 3.7 billion in 2022 to USD 4.9 billion by 2027, at a CAGR of 5.5%. Rising global prevalence of diabetes, venus leg ulcer, deep vein thrombosis and rapid growth in the older population with orthopedic disorders are likely to boost the adoption of compression therapy products. Growing cases of sports injuries, favorable clinical evidence for the use of compression therapy products in the management of several diseases and new developments in compression therapy by global giants are further anticipated to support the growth of the market.
“Compression pumps segment is expected to witness the highest growth rate during the forecast period”
On the basis of product, the compression therapy market is segmented into compression bandages, compression wraps, compression stockings, compression tapes, compression pumps, compression braces, and other compression garments. Compression pumps segment is anticipated to register the highest CAGR during the forecast period. Factors such as the increasing incidence of cancer, the rising prevalence of chronic venous diseases, and the growing number of hip and knee surgeries are expected to drive the growth of the compression pumps market during the forecast period.
“varicose vein treatment segment to capture the largest market share or compression therapy market in 2021, by application
On the basis of application, the compression therapy market is segmented into varicose vein treatment, deep vein thrombosis treatment, lymphedema treatment, leg ulcer treatment, and other applications. The varicose vein treatment segment accounted for the largest share the compression therapy market in 2021. The large share of this segment is mainly driven by the increasing prevalence of varicose veins, the high preference for compression therapy as the first line of treatment for varicose veins,
” The Asia Pacific market is expected to grow at the highest CAGR during the forecast period”
The global compression therapy market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World (Latin America and the Middle East & Africa). During the forecast period of Asia Pacific market is estimated to grow at the highest CAGR owing to the increase in patient population with diabetes, large geriatric patient pool, growing prevalence of orthopedic disorders and improved healthcare infrastructure in the region.
A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1–48%, Tier 2–36%, and Tier 3– 16%
• By Designation: C-level–10%, Director-level–14%, and Others–76%
• By Region: North America–40%, Europe–32%, Asia Pacific–20%, Latin America–5%, and the Middle East & Africa–3%
The major players operating in the compression therapy market are DJO, Inc. (US), BSN Medical (US), medi GmbH & Co. KG (Germany), Tactile Medical (US), SIGVARIS (Switzerland), Paul Hartmann AG (Germany), Sanyleg S.r.l. (Italy), 3M (US), ConvaTec Inc. (US), ArjoHuntleigh (Sweden), Julius Zorn GmbH (Germany), Bio Compression Systems, Inc. (US), Cardinal Health, Inc. (US), Smith & Nephew Plc (UK) and Mego Afek Ltd. (Israel).
Research Coverage
This report studies the compression therapy market based on product, technique, application, distribution channel, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.
This report provides insights on the following pointers:
Market Penetration: Comprehensive information on the product portfolios offered by the top players in the compression therapy market
Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the compression therapy market
Market Development: Comprehensive information on lucrative emerging regions
Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the compression therapy market
Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.
目次
1 INTRODUCTION 26
1.1 STUDY OBJECTIVES 26
1.2 MARKET DEFINITION 26
1.2.1 INCLUSIONS & EXCLUSIONS 27
1.3 STUDY SCOPE 28
1.3.1 MARKETS COVERED 28
1.3.2 YEARS CONSIDERED 29
1.4 CURRENCY 29
TABLE 1 STANDARD CURRENCY CONVERSION RATES 30
1.5 LIMITATIONS 30
1.6 KEY MARKET STAKEHOLDERS 30
1.7 SUMMARY OF CHANGES 30
2 RESEARCH METHODOLOGY 32
2.1 RESEARCH DATA 32
FIGURE 1 RESEARCH DESIGN 32
2.1.1 SECONDARY DATA 33
2.1.1.1 Indicative list of secondary sources 34
2.1.2 PRIMARY DATA 35
2.1.2.1 Key data from primary sources 36
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 36
2.2 MARKET ESTIMATION METHODOLOGY 37
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 37
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION 38
2.2.2 SALES/DISTRIBUTION CHANNEL-BASED MARKET ESTIMATION 39
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: GLOBAL COMPRESSION THERAPY MARKET 39
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 40
2.3 RECESSION IMPACT 41
2.3.1 IMPACT OF RECESSION ON COMPRESSION THERAPY MARKET 41
2.4 DATA TRIANGULATION 42
FIGURE 6 DATA TRIANGULATION METHODOLOGY 42
2.5 RESEARCH ASSUMPTIONS 43
2.6 RESEARCH LIMITATIONS 43
3 EXECUTIVE SUMMARY 44
FIGURE 7 COMPRESSION THERAPY MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION) 44
FIGURE 8 COMPRESSION THERAPY MARKET SHARE, BY TECHNIQUE, 2022 VS. 2027 (USD MILLION) 45
FIGURE 9 COMPRESSION THERAPY MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 45
FIGURE 10 COMPRESSION THERAPY MARKET SHARE, BY DISTRIBUTION CHANNEL, 2022 VS. 2027 46
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF COMPRESSION THERAPY MARKET 47
4 PREMIUM INSIGHTS 48
4.1 COMPRESSION THERAPY MARKET OVERVIEW 48
FIGURE 12 GROWING INCIDENCE OF SPORTS INJURIES AND FAVORABLE CLINICAL EVIDENCE TO DRIVE MARKET GROWTH 48
4.2 COMPRESSION THERAPY MARKET SHARE, BY PRODUCT, 2022 VS. 2027 (USD MILLION) 49
FIGURE 13 COMPRESSION PUMPS TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 49
4.3 COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2022 VS. 2027 (USD MILLION) 50
FIGURE 14 STATIC COMPRESSION THERAPY SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 50
4.4 COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2022 VS. 2027 (USD MILLION) 51
FIGURE 15 HOSPITALS & CLINICS TO ACCOUNT FOR LARGEST SHARE OF COMPRESSION THERAPY MARKET IN 2027 51
4.5 COMPRESSION THERAPY MARKET, BY REGION, 2020–2027 52
FIGURE 16 ASIA PACIFIC TO WITNESS FASTEST GROWTH IN MARKET DURING FORECAST PERIOD 52
5 MARKET OVERVIEW 53
5.1 INTRODUCTION 53
5.2 MARKET DYNAMICS 53
FIGURE 17 COMPRESSION THERAPY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 53
5.2.1 DRIVERS 54
5.2.1.1 Large target patient population 54
FIGURE 18 GERIATRIC POPULATION, BY REGION, 2015 VS. 2030 VS. 2050 55
5.2.1.2 Growing incidence of sports injuries and accidents 55
FIGURE 19 EUROPE: ROAD DEATHS PER MILLION INHABITANTS, BY COUNTRY, 2021 56
5.2.1.3 Increasing number of orthopedic procedures 56
5.2.1.4 Greater product affordability and market availability 57
5.2.1.5 Clinical evidence favoring adoption of compression therapy for management of target conditions 57
5.2.2 RESTRAINTS 58
5.2.2.1 Lack of universally accepted standards for compression products 58
5.2.2.2 Low patient compliance with compression garments 58
FIGURE 20 REASONS FOR NON-COMPLIANCE TO COMPRESSION THERAPY 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Growth potential offered by emerging markets 59
5.2.3.2 Growing patient awareness regarding benefits of compression therapy 60
5.2.3.3 Increased sales of off-the-shelf and online products 60
5.2.4 CHALLENGES 60
5.2.4.1 Significant adoption of alternative therapies for specific target indications 60
5.2.4.2 Increasing pricing pressure on market players 61
5.3 PORTER’S FIVE FORCES ANALYSIS 61
5.3.1 OVERVIEW 61
TABLE 2 COMPRESSION THERAPY MARKET: PORTER’S FIVE FORCES ANALYSIS 62
5.3.2 BARGAINING POWER OF BUYERS 62
5.3.3 BARGAINING POWER OF SUPPLIERS 62
5.3.4 THREAT FROM NEW ENTRANTS 62
5.3.5 THREAT FROM SUBSTITUTES 62
5.3.6 INTENSITY OF COMPETITIVE RIVALRY 63
5.4 PRICING TREND ANALYSIS 63
5.4.1 AVERAGE SELLING PRICE, BY PRODUCT 63
TABLE 3 AVERAGE PRICE OF KEY COMPRESSION THERAPY PRODUCTS, 2021 (USD) 63
5.4.2 AVERAGE SELLING PRICE, BY REGION 64
TABLE 4 REGIONAL PRICING ANALYSIS OF KEY COMPRESSION THERAPY PRODUCTS, 2021 (USD) 64
5.5 TECHNOLOGY ANALYSIS 64
5.5.1 WIRELESS BIOSENSORS 64
5.5.2 GARMENT MANUFACTURING TECHNOLOGIES 65
5.6 REGULATORY ANALYSIS 66
5.6.1 NORTH AMERICA 66
5.6.1.1 US 66
TABLE 5 US FDA: MEDICAL DEVICE CLASSIFICATION 67
TABLE 6 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 67
5.6.1.2 Canada 68
TABLE 7 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 68
FIGURE 21 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES 69
5.6.2 EUROPE 70
FIGURE 22 EUROPE: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (MDR) 71
5.6.3 ASIA PACIFIC 72
5.6.3.1 Japan 72
TABLE 8 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 72
5.6.3.2 China 73
TABLE 9 CHINA: CLASSIFICATION OF MEDICAL DEVICES 73
5.6.3.3 India 74
5.7 REIMBURSEMENT SCENARIO 75
TABLE 10 REIMBURSEMENT CODES FOR VARIOUS PROCEDURES AS OF 2021 75
5.8 VALUE CHAIN ANALYSIS 78
FIGURE 23 VALUE CHAIN ANALYSIS—MAXIMUM VALUE ADDED DURING MANUFACTURING PHASE 78
5.9 SUPPLY CHAIN ANALYSIS 79
5.9.1 PROMINENT COMPANIES 79
5.9.2 SMALL & MEDIUM-SIZED ENTERPRISES 79
5.9.3 END USERS 79
FIGURE 24 SUPPLY CHAIN ANALYSIS 79
5.10 ECOSYSTEM ANALYSIS 80
5.10.1 PARENT MARKET: ORTHOPEDIC IMPLANTS, SURGICAL DEVICES, AND SUPPORT PRODUCTS 80
5.11 PATENT ANALYSIS 81
FIGURE 25 PATENT ANALYSIS 81
5.12 TRADE ANALYSIS 81
TABLE 11 IMPORT DATA FOR COMPRESSION STOCKINGS (HS CODE 611510), BY COUNTRY, 2017–2021 (USD) 81
TABLE 12 EXPORT DATA FOR COMPRESSION STOCKINGS (HS CODE 611510), BY COUNTRY, 2017–2021 (USD) 82
5.13 KEY CONFERENCES & EVENTS, 2022–2023 82
5.13.1 COMPRESSION THERAPY MARKET: LIST OF MAJOR CONFERENCES & EVENTS 82
5.14 KEY STAKEHOLDERS & BUYING CRITERIA 84
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS, BY DISTRIBUTION CHANNEL 84
FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY DISTRIBUTION CHANNEL 84
TABLE 13 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY DISTRIBUTION CHANNEL (%) 84
5.14.2 BUYING CRITERIA 85
FIGURE 27 KEY BUYING CRITERIA, BY DISTRIBUTION CHANNEL 85
TABLE 14 KEY BUYING CRITERIA, BY DISTRIBUTION CHANNEL 85
6 COMPRESSION THERAPY MARKET, BY TECHNIQUE 86
6.1 INTRODUCTION 87
TABLE 15 COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 87
6.2 STATIC COMPRESSION THERAPY 87
6.2.1 PROCEDURAL ADVANTAGES OF STATIC COMPRESSION THERAPY TO DRIVE GROWTH 87
TABLE 16 STATIC COMPRESSION THERAPY MARKET, BY REGION, 2020–2027 (USD MILLION) 88
6.3 DYNAMIC COMPRESSION THERAPY 89
6.3.1 RISING INCIDENCE OF TARGET CONDITIONS TO SUPPORT MARKET 89
TABLE 17 DYNAMIC COMPRESSION THERAPY MARKET, BY REGION, 2020–2027 (USD MILLION) 89
7 COMPRESSION THERAPY MARKET, BY PRODUCT 90
7.1 INTRODUCTION 91
TABLE 18 COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 91
7.2 COMPRESSION BANDAGES 91
7.2.1 LIMITED AVAILABILITY OF MEDICAL REIMBURSEMENTS FOR VARICOSE VEIN SURGERIES TO RESTRAIN MARKET GROWTH 91
TABLE 19 COMPRESSION BANDAGES MARKET, BY REGION, 2020–2027 (USD MILLION) 92
TABLE 20 COMPRESSION BANDAGES MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 92
TABLE 21 COMPRESSION BANDAGES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 93
TABLE 22 COMPRESSION BANDAGES MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 93
7.3 COMPRESSION WRAPS 94
7.3.1 RISING GERIATRIC POPULATION AND INCREASING INCIDENCE OF SPORTS INJURIES TO DRIVE MARKET 94
TABLE 23 COMPRESSION WRAPS MARKET, BY REGION, 2020–2027 (USD MILLION) 94
TABLE 24 COMPRESSION WRAPS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 94
TABLE 25 COMPRESSION WRAPS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 95
TABLE 26 COMPRESSION WRAPS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 95
7.4 COMPRESSION STOCKINGS 96
TABLE 27 COMPRESSION STOCKINGS MARKET, BY TYPE, 2020–2027 (USD MILLION) 96
TABLE 28 COMPRESSION STOCKINGS MARKET, BY REGION, 2020–2027 (USD MILLION) 97
TABLE 29 COMPRESSION STOCKINGS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 97
TABLE 30 COMPRESSION STOCKINGS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 98
TABLE 31 COMPRESSION STOCKINGS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 98
7.4.1 CLASS I COMPRESSION STOCKINGS 99
7.4.1.1 Advantages such as comfort and durability to drive demand for class I stockings 99
TABLE 32 CLASS I COMPRESSION STOCKINGS MARKET, BY REGION, 2020–2027 (USD MILLION) 99
7.4.2 CLASS II COMPRESSION STOCKINGS 100
7.4.2.1 Increasing number of lymphedema and DVT patients to fuel demand 100
TABLE 33 CLASS II COMPRESSION STOCKINGS MARKET, BY REGION, 2020–2027 (USD MILLION) 100
7.4.3 CLASS III COMPRESSION STOCKINGS 100
7.4.3.1 High level of compression provided to boost adoption of class III stockings 100
TABLE 34 CLASS III COMPRESSION STOCKINGS MARKET, BY REGION, 2020–2027 (USD MILLION) 101
7.5 COMPRESSION TAPES 101
7.5.1 ABILITY TO PREVENT FURTHER MUSCLE INJURY TO DRIVE DEMAND FOR COMPRESSION TAPES 101
TABLE 35 COMPRESSION TAPES MARKET, BY REGION, 2020–2027 (USD MILLION) 102
TABLE 36 COMPRESSION TAPES MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 102
TABLE 37 COMPRESSION TAPES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 103
TABLE 38 COMPRESSION TAPES MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 103
7.6 COMPRESSION PUMPS 104
TABLE 39 COMPRESSION PUMPS MARKET, BY TYPE, 2020–2027 (USD MILLION) 105
TABLE 40 COMPRESSION PUMPS MARKET, BY REGION, 2020–2027 (USD MILLION) 105
TABLE 41 COMPRESSION PUMPS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 105
TABLE 42 COMPRESSION PUMPS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 106
TABLE 43 COMPRESSION PUMPS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 106
7.6.1 INTERMITTENT PUMPS 107
7.6.1.1 Availability of wide range of intermittent pumps with varying designs and complexity to boost demand 107
TABLE 44 INTERMITTENT COMPRESSION PUMPS MARKET, BY REGION, 2020–2027 (USD MILLION) 107
7.6.2 SEQUENTIAL PUMPS 107
7.6.2.1 Wide usage to prevent development of DVT to boost growth 107
TABLE 45 SEQUENTIAL COMPRESSION PUMPS MARKET, BY REGION, 2020–2027 (USD MILLION) 107
7.7 COMPRESSION BRACES 108
7.7.1 RISING NUMBER OF JOINT REPLACEMENT SURGERIES TO SUPPORT MARKET 108
TABLE 46 COMPRESSION BRACES MARKET, BY REGION, 2020–2027 (USD MILLION) 108
TABLE 47 COMPRESSION BRACES MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 108
TABLE 48 COMPRESSION BRACES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 109
TABLE 49 COMPRESSION BRACES MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 109
7.8 OTHER COMPRESSION GARMENTS 110
TABLE 50 OTHER COMPRESSION GARMENTS MARKET, BY REGION, 2020–2027 (USD MILLION) 110
TABLE 51 OTHER COMPRESSION GARMENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 110
TABLE 52 OTHER COMPRESSION GARMENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 111
TABLE 53 OTHER COMPRESSION GARMENTS MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 111
8 COMPRESSION THERAPY MARKET, BY APPLICATION 112
8.1 INTRODUCTION 113
TABLE 54 COMPRESSION THERAPY MARKET, BY APPLICATION, 2020–2027(USD MILLION) 113
8.2 VARICOSE VEIN TREATMENT 113
8.2.1 GROWING GLOBAL PREVALENCE OF VARICOSE VEINS TO DRIVE MARKET 113
TABLE 55 COMPRESSION THERAPY MARKET FOR VARICOSE VEIN TREATMENT, BY REGION, 2020–2027 (USD MILLION) 114
8.3 DEEP VEIN THROMBOSIS TREATMENT 115
8.3.1 AVAILABILITY OF ALTERNATIVE TREATMENTS FOR DVT TO LIMIT GROWTH 115
TABLE 56 COMPRESSION THERAPY MARKET FOR DEEP VEIN THROMBOSIS TREATMENT, BY REGION, 2020–2027 (USD MILLION) 116
8.4 LYMPHEDEMA TREATMENT 116
8.4.1 RISING INCIDENCE OF CANCER TO CONTRIBUTE TO GROWTH 116
TABLE 57 COMPRESSION THERAPY MARKET FOR LYMPHEDEMA TREATMENT, BY REGION, 2020–2027 (USD MILLION) 117
8.5 LEG ULCER TREATMENT 117
8.5.1 GROWING DISEASE BURDEN ACROSS MAJOR COUNTRIES TO BOOST MARKET 117
TABLE 58 COMPRESSION THERAPY MARKET FOR LEG ULCER TREATMENT, BY REGION, 2020–2027 (USD MILLION) 118
8.6 OTHER APPLICATIONS 119
TABLE 59 COMPRESSION THERAPY MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 119
9 COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL 120
9.1 INTRODUCTION 121
TABLE 60 COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 121
9.2 PHARMACIES & RETAILERS 121
9.2.1 RISING ADOPTION OF OFF-THE-SHELF PRODUCTS TO SUPPORT MARKET GROWTH 121
TABLE 61 COMPRESSION THERAPY MARKET FOR PHARMACIES & RETAILERS, BY REGION, 2020–2027 (USD MILLION) 122
9.3 E-COMMERCE PLATFORMS 122
9.3.1 E-COMMERCE PLATFORMS TO REGISTER HIGH CAGR DURING FORECAST PERIOD 122
TABLE 62 COMPRESSION THERAPY MARKET FOR E-COMMERCE PLATFORMS, BY REGION, 2020–2027 (USD MILLION) 123
9.4 HOSPITALS & CLINICS 123
9.4.1 HEALTHCARE INFRASTRUCTURAL IMPROVEMENTS TO BOOST GROWTH 123
TABLE 63 COMPRESSION THERAPY MARKET FOR HOSPITALS & CLINICS, BY REGION, 2020–2027 (USD MILLION) 124
9.5 HOME CARE SETTINGS 124
9.5.1 GROWING INCLINATION TOWARD HOME HEALTHCARE TO DRIVE MARKET 124
TABLE 64 COMPRESSION THERAPY MARKET FOR HOME CARE SETTINGS, BY REGION, 2020–2027 (USD MILLION) 125
10 COMPRESSION THERAPY MARKET, BY REGION 126
10.1 INTRODUCTION 127
TABLE 65 COMPRESSION THERAPY MARKET, BY REGION, 2020–2027 (USD MILLION) 127
10.2 NORTH AMERICA 127
FIGURE 28 NORTH AMERICA: COMPRESSION THERAPY MARKET SNAPSHOT 128
TABLE 66 NORTH AMERICA: COMPRESSION THERAPY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 129
TABLE 67 NORTH AMERICA: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 129
TABLE 68 NORTH AMERICA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 130
TABLE 69 NORTH AMERICA: COMPRESSION THERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 130
TABLE 70 NORTH AMERICA: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 131
10.2.1 US 131
10.2.1.1 Rising number of sports injuries to drive market growth 131
TABLE 71 US: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 132
10.2.2 CANADA 132
10.2.2.1 Increasing incidence of target diseases to support growth 132
TABLE 72 CANADA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 133
10.3 EUROPE 134
TABLE 73 EUROPE: COMPRESSION THERAPY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 134
TABLE 74 EUROPE: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 135
TABLE 75 EUROPE: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 135
TABLE 76 EUROPE: COMPRESSION THERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 136
TABLE 77 EUROPE: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 136
10.3.1 GERMANY 137
10.3.1.1 Inconsistent reimbursement for compression therapy products to restrain market growth 137
TABLE 78 GERMANY: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 137
10.3.2 UK 138
10.3.2.1 Rising prevalence of lymphedema and DVT to drive market 138
TABLE 79 UK: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 139
10.3.3 FRANCE 139
10.3.3.1 High incidence of diabetes to drive demand for compression therapy 139
TABLE 80 FRANCE: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 140
10.3.4 ITALY 140
10.3.4.1 Rising awareness about preventive care for musculoskeletal injuries to fuel growth 140
TABLE 81 ITALY: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 141
10.3.5 SPAIN 141
10.3.5.1 Growing presence of key manufacturers to increase access to compression therapy products 141
TABLE 82 SPAIN: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 142
10.3.6 REST OF EUROPE 142
TABLE 83 HIP AND KNEE SURGERY PROCEDURES (PER 100,000 PEOPLE) IN EUROPEAN COUNTRIES 142
TABLE 84 REST OF EUROPE: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 143
10.4 ASIA PACIFIC 143
FIGURE 29 ASIA PACIFIC: COMPRESSION THERAPY MARKET SNAPSHOT 144
TABLE 85 ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 145
TABLE 86 ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 145
TABLE 87 ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 146
TABLE 88 ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 146
TABLE 89 ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 147
10.4.1 JAPAN 147
10.4.1.1 Japan to dominate Asia Pacific compression therapy market 147
TABLE 90 JAPAN: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 148
10.4.2 CHINA 148
10.4.2.1 Modernization of healthcare facilities to drive market growth 148
TABLE 91 CHINA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 149
10.4.3 INDIA 149
10.4.3.1 Growing number of hip & knee surgeries to support market 149
TABLE 92 INDIA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 150
10.4.4 AUSTRALIA 150
10.4.4.1 Government subsidies related to compression garments for lymphedema patients to promote growth 150
TABLE 93 AUSTRALIA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 151
10.4.5 SOUTH KOREA 151
10.4.5.1 Increasing number of plastic surgeries to drive demand for compression garments 151
TABLE 94 SOUTH KOREA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 152
10.4.6 REST OF ASIA PACIFIC 152
TABLE 95 REST OF ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 153
10.5 LATIN AMERICA 153
TABLE 96 LATIN AMERICA: COMPRESSION THERAPY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 154
TABLE 97 LATIN AMERICA: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 154
TABLE 98 LATIN AMERICA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 155
TABLE 99 LATIN AMERICA: COMPRESSION THERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 155
TABLE 100 LATIN AMERICA: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 156
10.5.1 BRAZIL 156
10.5.1.1 Rising number of cosmetic surgeries to support market 156
TABLE 101 BRAZIL: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 157
10.5.2 MEXICO 157
10.5.2.1 Lack of reimbursement for bracing products to limit growth 157
TABLE 102 MEXICO: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 158
10.5.3 REST OF LATIN AMERICA 158
TABLE 103 REST OF LATIN AMERICA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 159
10.6 MIDDLE EAST & AFRICA 159
10.6.1 UNFAVORABLE REIMBURSEMENT SCENARIO TO HAMPER MARKET GROWTH 159
TABLE 104 MIDDLE EAST & AFRICA: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 160
TABLE 105 MIDDLE EAST & AFRICA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 160
TABLE 106 MIDDLE EAST & AFRICA: COMPRESSION THERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 161
TABLE 107 MIDDLE EAST & AFRICA: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2020–2027 (USD MILLION) 161
11 COMPETITIVE LANDSCAPE 162
11.1 INTRODUCTION 162
11.2 STRATEGIES ADOPTED BY KEY PLAYERS 162
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN COMPRESSION THERAPY MARKET 163
TABLE 108 STRATEGIES ADOPTED BY KEY COMPRESSION THERAPY PRODUCT MANUFACTURING COMPANIES 163
11.3 REVENUE SHARE ANALYSIS 164
FIGURE 30 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN COMPRESSION THERAPY MARKET 164
11.4 MARKET SHARE ANALYSIS 164
FIGURE 31 COMPRESSION THERAPY MARKET SHARE, BY KEY PLAYER, 2021 165
11.5 COMPETITIVE SITUATIONS AND TRENDS 165
TABLE 109 COMPRESSION THERAPY MARKET: DEGREE OF COMPETITION 165
11.6 COMPANY EVALUATION QUADRANT 166
11.7 COMPETITIVE LEADERSHIP MAPPING: COMPANY EVALUATION QUADRANT (2021) 166
11.7.1 STARS 166
11.7.2 EMERGING LEADERS 166
11.7.3 PERVASIVE PLAYERS 166
11.7.4 PARTICIPANTS 166
FIGURE 32 COMPRESSION THERAPY MARKET: COMPETITIVE LEADERSHIP MAPPING (2021) 167
11.8 COMPETITIVE LEADERSHIP MAPPING: START-UP/SME EVALUATION QUADRANT (2021) 168
11.8.1 PROGRESSIVE COMPANIES 168
11.8.2 STARTING BLOCKS 168
11.8.3 RESPONSIVE COMPANIES 168
11.8.4 DYNAMIC COMPANIES 168
FIGURE 33 COMPRESSION THERAPY MARKET: COMPETITIVE LEADERSHIP MAPPING (SMES/START-UPS) (2021) 169
11.9 COMPETITIVE BENCHMARKING 170
FIGURE 34 PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS OF TOP PLAYERS IN COMPRESSION THERAPY MARKET 170
TABLE 110 COMPANY PRODUCT FOOTPRINT 170
TABLE 111 COMPANY REGIONAL FOOTPRINT 171
11.10 COMPETITIVE SCENARIO 171
11.10.1 PRODUCT LAUNCHES 171
11.10.2 DEALS 172
11.10.3 OTHER DEVELOPMENTS 172
12 COMPANY PROFILES 173
12.1 KEY PLAYERS 173
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 3M 173
TABLE 112 3M: BUSINESS OVERVIEW 173
FIGURE 35 3M: COMPANY SNAPSHOT (2021) 174
12.1.2 ARJOHUNTLEIGH 176
TABLE 113 ARJOHUNTLEIGH: BUSINESS OVERVIEW 176
FIGURE 36 ARJOHUNTLEIGH: COMPANY SNAPSHOT (2021) 177
12.1.3 BIO COMPRESSION SYSTEMS, INC. 179
TABLE 114 BIO COMPRESSION SYSTEMS, INC.: BUSINESS OVERVIEW 179
12.1.4 BSN MEDICAL (A SUBSIDIARY OF ESSITY) 180
TABLE 115 ESSITY: BUSINESS OVERVIEW 180
FIGURE 37 ESSITY: COMPANY SNAPSHOT (2021) 181
12.1.5 CARDINAL HEALTH, INC. 183
TABLE 116 CARDINAL HEALTH, INC.: BUSINESS OVERVIEW 183
FIGURE 38 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT (2022) 184
12.1.6 CONVATEC INC. 186
TABLE 117 CONVATEC INC.: BUSINESS OVERVIEW 186
FIGURE 39 CONVATEC INC.: COMPANY SNAPSHOT (2021) 187
12.1.7 DJO, LLC (A SUBSIDIARY OF COLFAX CORPORATION) 189
TABLE 118 DJO, LLC: BUSINESS OVERVIEW 189
FIGURE 40 COLFAX CORPORATION: COMPANY SNAPSHOT (2021) 190
12.1.8 JULIUS ZORN GMBH 193
TABLE 119 JULIUS ZORN GMBH: BUSINESS OVERVIEW 193
12.1.9 MEDI GMBH & CO. KG 195
TABLE 120 MEDI GMBH & CO. KG: BUSINESS OVERVIEW 195
12.1.10 PAUL HARTMANN AG 198
TABLE 121 PAUL HARTMANN AG: BUSINESS OVERVIEW 198
FIGURE 41 PAUL HARTMANN AG: COMPANY SNAPSHOT (2021) 199
12.1.11 SANYLEG S.R.L. 201
TABLE 122 SANYLEG S.R.L.: BUSINESS OVERVIEW 201
12.1.12 SIGVARIS GROUP 204
TABLE 123 SIGVARIS GROUP: BUSINESS OVERVIEW 204
12.1.13 SMITH & NEPHEW PLC 206
TABLE 124 SMITH & NEPHEW PLC: BUSINESS OVERVIEW 206
FIGURE 42 SMITH & NEPHEW PLC: COMPANY SNAPSHOT (2021) 207
12.1.14 TACTILE SYSTEMS TECHNOLOGY, INC. (“TACTILE MEDICAL”) 209
TABLE 125 TACTILE MEDICAL: BUSINESS OVERVIEW 209
FIGURE 43 TACTILE MEDICAL: COMPANY SNAPSHOT (2021) 210
12.1.15 MEGO AFEK LTD. 212
TABLE 126 MEGO AFEK LTD.: BUSINESS OVERVIEW 212
12.2 OTHER PLAYERS 214
12.2.1 MEDLINE INDUSTRIES, LP 214
12.2.2 GOTTFRIED MEDICAL, INC. 215
12.2.3 THERMOTEK, INC. 216
12.2.4 BAUERFEIND AG 217
12.2.5 OFA BAMBERG GMBH 218
12.2.6 ACI MEDICAL, LLC 218
12.2.7 AIROS MEDICAL INC. 219
12.2.8 BARCELCOM TÊXTEIS, S.A. 220
12.2.9 CIZETA MEDICALI S.P.A. 221
12.2.10 BÖSL MEDIZINTECHNIK 222
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 223
13.1 DISCUSSION GUIDE 223
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 228
13.3 CUSTOMIZATION OPTIONS 230
13.4 RELATED REPORTS 230
13.5 AUTHOR DETAILS 231